Medical Innovation Act of 2024

Bill 118 hr 10238, also known as the "Medical Research Investment and Innovation Act," aims to authorize the collection of supplemental payments in order to increase congressional investments in medical research. The bill seeks to provide additional funding for research in various medical fields, with the goal of advancing scientific knowledge and improving healthcare outcomes.

The bill outlines a plan to collect these supplemental payments through a combination of sources, including increased taxes on certain industries and reallocating funds from other government programs. The funds collected would be specifically earmarked for medical research initiatives, such as funding for research grants, clinical trials, and the development of new medical technologies.

In addition to increasing funding for medical research, the bill also includes provisions for promoting innovation in the healthcare industry. This includes measures to streamline the regulatory process for new medical treatments and devices, as well as incentives for private sector investment in medical research. Overall, the Medical Research Investment and Innovation Act aims to bolster congressional support for medical research and innovation, with the ultimate goal of improving healthcare outcomes for all Americans.